Telix Pharmaceuticals revenue rises 19% to US$245M
Telix Pharmaceuticals (ASX:TLX) generated US$245 million in group revenue during the third quarter of 2026, up 19% in the prior-year period.
Telix Pharmaceuticals (ASX:TLX) generated US$245 million in group revenue during the third quarter of 2026, up 19% in the prior-year period.
Transurban (ASX:TCL) reported a 3.1% increase in average daily traffic across its toll road network for the September quarter.
Yancoal Australia (ASX:YAL) boosted its cash balance by $340 million during the September 2026 quarter, supported by higher coal pricing.
P&N Bank reported an annual net profit of $30.4 million for the 12 months ended June 30, representing a 7.6% increase from the previous financial year.
Netflix (NASDAQ:NFLX) reported third-quarter 2026 revenue of $12.87 billion, up 11.8% year over year, supported by subscription pricing, membership growth and advertising.
SpaceX (NASDAQ:SPCX) generated third-quarter 2026 revenue of $14.58 billion, exceeding analysts' $12.7 billion forecast as its AI and connectivity businesses expanded.
United Airlines (NASDAQ:UAL) reported record third-quarter 2026 operating revenue of $17.9 billion, up 17.4% year over year, supported by passenger and loyalty demand.
Phillips 66 (NYSE:PSX) locked out union-represented employees at its Bayway Refinery in Linden, New Jersey, after a temporary labor contract extension expired.
Eli Lilly (NYSE:LLY) shares surged 5.45% to a reported intraday record of $1,307.91 on Tuesday, October 20, amid a broader healthcare stock rally.
Creative Medical Technology Holdings (NASDAQ:CELZ) reported that 28 of 30 patients, or 93%, met study-defined response criteria in its Ultrasome knee osteoarthritis pilot.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy